Our results demonstrate that ALN-induced inhibition of invasion/migration, and disruption of F-actin organization in prostate cancer cells were associated with markedly lowered levels of cofilin protein in vitro, and in an in vivo tumor model. This evidence concerns the gene ARLN and prostate carcinoma.